Astrazeneca Plc Adr Stock Today

AZN Stock  USD 67.75  0.51  0.75%   

Performance

2 of 100

 
Low
 
High
Weak

Odds Of Distress

Less than 12

 
100  
 
Zero
Low
AstraZeneca PLC is selling at 67.75 as of the 29th of March 2024; that is -0.75 percent decrease since the beginning of the trading day. The stock's open price was 68.26. AstraZeneca PLC has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for AstraZeneca PLC ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
12th of May 1993
Category
Healthcare
Classification
Health Care
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. The company has 3.1 B outstanding shares of which 10.48 M shares are presently shorted by investors with about 1.87 days to cover. More on AstraZeneca PLC ADR

Moving against AstraZeneca Stock

  0.48MGNX MacroGenics Financial Report 14th of May 2024 PairCorr

AstraZeneca Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOPascal Soriot
Thematic IdeaCompulsion (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, Nasdaq 100, NASDAQ 100 Pre, ARCA Pharmaceutical, NASDAQ Composite, NASDAQ Health Care, Compulsion, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering AstraZeneca PLC report their recommendations after researching AstraZeneca PLC's financial statements, talking to executives and customers, or listening in on AstraZeneca PLC's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering AstraZeneca PLC ADR. The AstraZeneca consensus assessment is calculated by taking the average forecast from all of the analysts covering AstraZeneca PLC.
Financial Strength
Based on the measurements of operating efficiency obtained from AstraZeneca PLC's historical financial statements, AstraZeneca PLC ADR may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of AstraZeneca PLC ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.10.0589
Way Up
Slightly volatile
Asset Turnover0.790.453
Way Up
Slightly volatile
Gross Profit Margin0.870.8195
Notably Up
Very volatile
Net Debt23.9 B22.8 B
Sufficiently Up
Slightly volatile
Total Current Liabilities32.1 B30.5 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total33 B31.4 B
Sufficiently Up
Slightly volatile
Total Assets106.2 B101.1 B
Sufficiently Up
Slightly volatile
Total Current Assets15.3 B25.1 B
Way Down
Slightly volatile
Total Cash From Operating Activities10.9 B10.3 B
Sufficiently Up
Slightly volatile
AstraZeneca PLC's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to AstraZeneca PLC's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
AstraZeneca PLC's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of AstraZeneca PLC's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AstraZeneca PLC's financial leverage. It provides some insight into what part of AstraZeneca PLC's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on AstraZeneca PLC's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how AstraZeneca PLC deploys its capital and how much of that capital is borrowed.
Liquidity
AstraZeneca PLC cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 28.62 B in debt with debt to equity (D/E) ratio of 0.89, which is OK given its current industry classification. AstraZeneca PLC ADR has a current ratio of 0.79, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity.

Depreciation

5.18 Billion
AstraZeneca PLC ADR (AZN) is traded on NASDAQ Exchange in USA. It is located in 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA and employs 89,900 people. AstraZeneca PLC is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 210.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC ADR runs under Pharmaceuticals sector within Health Care industry. The entity has 3.1 B outstanding shares of which 10.48 M shares are presently shorted by investors with about 1.87 days to cover. AstraZeneca PLC ADR has about 4.52 B in cash with 10.35 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership Allocation
AstraZeneca PLC holds a total of 3.1 Billion outstanding shares. Almost 83.0 percent of AstraZeneca PLC outstanding shares are held by general public with 16.79 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AstraZeneca Ownership Details

AstraZeneca Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of AstraZeneca PLC jumping above the current price in 90 days from now is about 12.93%. The AstraZeneca PLC ADR probability density function shows the probability of AstraZeneca PLC stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon AstraZeneca PLC has a beta of 0.8805. This suggests AstraZeneca PLC ADR market returns are highly reactive to returns on the market. As the market goes up or down, AstraZeneca PLC is expected to follow. Additionally, astraZeneca PLC ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 67.75HorizonTargetOdds Above 67.75
86.86%90 days
 67.75 
12.93%
Based on a normal probability distribution, the odds of AstraZeneca PLC to move above the current price in 90 days from now is about 12.93 (This AstraZeneca PLC ADR probability density function shows the probability of AstraZeneca Stock to fall within a particular range of prices over 90 days) .

AstraZeneca Stock Institutional Holders

Institutional Holdings refers to the ownership stake in AstraZeneca PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AstraZeneca PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AstraZeneca PLC's value.
InstituionRecorded OnShares
Franklin Resources Inc2023-12-31
9.8 M
Atlantic Trust Group, Llc2023-09-30
9.5 M
Capital World Investors2023-12-31
9.3 M
Fisher Asset Management, Llc2023-09-30
9.2 M
Putnam Investments Llc2023-12-31
7.7 M
Blackrock Inc2023-09-30
6.4 M
Farallon Capital Management, L.l.c.2023-09-30
6.1 M
Nuveen Asset Management, Llc2023-09-30
5.3 M
Amvescap Plc.2023-09-30
4.9 M
T. Rowe Price Associates, Inc.2023-12-31
52.3 M
Wellington Management Company Llp2023-12-31
49.4 M
View AstraZeneca PLC Diagnostics

AstraZeneca PLC Historical Income Statement

AstraZeneca PLC ADR Income Statement is one of the three primary financial statements used for reporting AstraZeneca's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AstraZeneca PLC ADR revenue and expense. AstraZeneca PLC Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, AstraZeneca PLC's Interest Income is very stable compared to the past year. View More Fundamentals

AstraZeneca Stock Against Markets

Picking the right benchmark for AstraZeneca PLC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AstraZeneca PLC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AstraZeneca PLC is critical whether you are bullish or bearish towards AstraZeneca PLC ADR at a given time. Please also check how AstraZeneca PLC's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

AstraZeneca PLC Corporate Directors

AstraZeneca PLC corporate directors refer to members of an AstraZeneca PLC board of directors. The board of directors generally takes responsibility for the AstraZeneca PLC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AstraZeneca PLC's board members must vote for the resolution. The AstraZeneca PLC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Marc DunoyerChief Financial Officer, Executive DirectorProfile
Sherilyn McCoyNon-Executive Independent DirectorProfile
Genevieve BergerNon-Executive Independent DirectorProfile
Nazneen RahmanNon-Executive Independent DirectorProfile

How to buy AstraZeneca Stock?

Before investing in AstraZeneca PLC, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AstraZeneca PLC. To buy AstraZeneca PLC stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of AstraZeneca PLC. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase AstraZeneca PLC stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located AstraZeneca PLC ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased AstraZeneca PLC ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AstraZeneca PLC ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy AstraZeneca Stock please use our How to Invest in AstraZeneca PLC guide.

Already Invested in AstraZeneca PLC ADR?

The danger of trading AstraZeneca PLC ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AstraZeneca PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AstraZeneca PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AstraZeneca PLC ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.